Showing results (1721-1730 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|July 27, 2005
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphomaK P Papadopoulos, W Noguera-Irizarry, L Wiebe, et al.Bone Marrow Transplantation|June 7, 2005
Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective studyS-J Choi, J-H Lee, J-H Lee, et al.Bone Marrow Transplantation|June 7, 2005
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemiaC Hosing, R M Saliba, M Shahjahan, et al.Bone Marrow Transplantation|July 12, 2005
Imatinib therapy prior to myeloablative allogeneic stem cell transplantationJ M Zaucha, W Prejzner, S Giebel, et al.Bone Marrow Transplantation|July 19, 2005
Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantationH Narimatsu, M Kami, S Hara, et al.Bone Marrow Transplantation|July 19, 2005
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF aloneS M Devine, R A Brown, V Mathews, et al.Bone Marrow Transplantation|August 3, 2005
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantationM Pihusch, H Wegner, P Goehring, et al.Bone Marrow Transplantation|August 3, 2005
Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipientsN M A Blijlevens, J P Donnelly, B E DePauwBone Marrow Transplantation|February 28, 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocolJ-P Lotz, P Pautier, F Selle, et al.Bone Marrow Transplantation|February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patientsD O'Shea, C Giles, E Terpos, et al.Pageof 993